Request Demo!

Press Releases

Annual and special shareholders meeting of ZoomMed inc.

Montreal, November 29, 2016 – ZoomMed Inc. (TSX Venture Exchange: ZMD), announces it has held its Annual and Special Meeting of Shareholders on November 29, 2016. The meeting was held for the purpose of: To receive the consolidated financial statements of ZoomMed for the fiscal year ended May 31, 2016 and the independent auditors’ report;…

Read More

ZoomMed announces the grant of options

Montreal, January 21, 2016 – ZoomMed inc. (TSX Venture: ZMD) announces that during its  Board of directors held on January 15, 2016, the Board agreed to grant options allows its holder to purchase one common share of ZoomMed at a price of twenty one cents ($0.21). 600,000 stock options have been grant to its directors…

Read More

Annual and special shareholders meeting of ZoomMed inc.

Montreal, November 20, 2015 – ZoomMed Inc. (TSX Venture Exchange: ZMD), announces it has held its Annual and Special Meeting of Shareholders as at November 20, 2015. The meeting was held for the purpose of: To receive the consolidated financial statements of ZoomMed for the fiscal year ended May 31, 2015 and the independent auditors’…

Read More

ZoomMed closes the sale to Familiprix for $2,000,000 of its ownership rights of “PraxisLab”

Montreal, November 19, 2015 – ZoomMed Inc. (TSX : ZMD) announces that it has closed the sale of all of its ownership of intellectual property rights of “PraxisLab” to Familiprix inc. for a cash consideration of $2,000,000. Already in November 2013, Familiprix had previously acquired a limited ownership of the intellectual property rights of “PraxisLab”…

Read More

ZoomMed obtains the american distribution rights of Rx Vigilance “Quick Glance”

Montreal, November 19, 2015 – ZoomMed Inc. (TSX : ZMD) is proud to announce that it has entered into an agreement with Vigilance Santé Inc. for the distribution rights, in the American market, of their widely acclaimed therapeutic advisor, the Rx Vigilance “Quick Glance”. Rx Vigilance “Quick Glance” is one of the cornerstone elements in…

Read More

Change to the Board of Directors

Montreal, August 5, 2015 – ZoomMed Inc. (TSX-V: ZMD) (the “Corporation” or “ZoomMed”) – The Corporation announces the resignation of Mr. André Marmet as director of the Corporation, effective immediately. Mr. André Marmet was serving on the Board of Directors since the incorporation of the Corporation in 2005. The Corporation and the Board of Directors…

Read More

Annual and special shareholders meeting

Montreal, November 28, 2014 – ZoomMed Inc. (TSX Venture Exchange: ZMD), announces it has held its Annual and Special Meeting of Shareholders as at November 28, 2014. The purpose of the meeting was:   To receive the consolidated financial statements of ZoomMed for the fiscal year ended May 31, 2014 and the independent auditors’ report;…

Read More

ZMD sells interest in its ZRx Prescriber for up to $6,800,000.

ZoomMed to focus on U.S. market by selling to TELUS Health an interest in its ZRx Prescriber Technology and related Canadian operations   Montreal, September 3, 2014 – ZoomMed Inc. (TSX-V: ZMD) – ZoomMed has sold an interest in the technology underlying its ZRx Prescriber Technology and certain related Canadian operations to TELUS Health for up…

Read More

ZoomMed signs an agreement with Desjardins Insurance DSF

Montreal, February 17, 2014 – ZoomMed Inc. (TSX-V: ZMD) (the “Company” or “ZoomMed”) is pleased to announce that it has signed an agreement with Desjardins Insurance for the development and operation of a project focusing for a web-based solution to integrate selected insurance plan information into the ZRx Prescriber to provide physician users with information…

Read More

Closing of a new financing and the repayment of its $1,5M convertible debenture

Montreal, January 16, 2014 – ZoomMed Inc. (TSX-V: ZMD) (the “Corporation”) announces the closing of a non-revolving loan, for a principal amount not exceeding US$2,000,000 (the “Loan”), of which US$1,664,318.92 has already been advanced, and the repayment of the CA$1,500,000 current convertible debenture.     The new secured debenture’s maturity date is December 31, 2014…

Read More